Showing results (111-120 of 160) with videos related to
Sort By:
Pageof 16
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2024
Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopeniaMoritz B Bastian, Maike Sieben, Arne Blickle, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2020
New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamideFlorian Rosar, Sebastian Dewes, Martin Ries, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2025
Expanding the scope of PSMA-RLT: evaluating treatment in challenging mCRPC patients with poor performance status (ECOG 3)Moritz B Bastian, Benedikt Wörl, Arne Blickle, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2011
Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99mTc-MAA accumulation in the anterior abdominal wall?Hojjat Ahmadzadehfar, Markus Möhlenbruch, Amir Sabet, et al.Organic & Biomolecular Chemistry|October 3, 2018
Optimized synthesis and indium complex formation with the bifunctional chelator NODIA-MeChristian Weinmann, Jason P Holland, Tilman Läppchen, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|February 23, 2024
[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysisFlorian Rosar, Caroline Burgard, Elena Larsen, et al.Scientific Reports|May 17, 2024
Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLTFlorian Rosar, Caroline Burgard, Scott David, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumorsSamer Ezziddin, Timur Logvinski, Charlotte Yong-Hing, et al.Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Safety and Efficacy of Selective Internal Radionuclide Therapy with 90Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial ChemoembolizationAlexander Bellendorf, Nicolai Mader, Stefan P Mueller, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotateSamer Ezziddin, Amir Sabet, Florian Heinemann, et al.Pageof 16